Jeffrey Cummings
Neurology · Los Angeles, CANPI 1457376329
Payments from drug & device makers
Across 515 payments — averaging $3954.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teikoku Pharma USA, Inc.$1.1M
- Grifols, S.A.$158K
- Eisai Inc.$127K
- Biogen$116K
- Acadia Pharmaceuticals Inc$69K
- Merck$56K
- plus $403K from 30 others
Across 11 payments — averaging $5526.82 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Biogen$24K
- Novo Nordisk AS$17K
- Eli Lilly$10K
- Novartis$10K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,036,379 in reported general payments places this provider in the 95th percentile of 1,996 neurology providers in California.
Other neurology in Los Angeles
- Timothy CloughesyLos Angeles$33.1M
- Perry ShiehLos Angeles$8.2M
- Jeffrey SaverLos Angeles$2.9M
- David PiccioniLos Angeles$2.9M
- David LiebeskindLos Angeles$2.7M
- Michele TagliatiLos Angeles$2.5M
- Jennifer HuiLos Angeles$2.4M
- Susan PerlmanLos Angeles$2.2M
- Bryan SpannLos Angeles$1.8M
- Lilyana AmezcuaLos Angeles$1.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.